Thomas Schinecker

Last updated
Thomas Schinecker
Dr
Born (1975-04-23) April 23, 1975 (age 49) [1]
Simbach am Inn, Germany.
Nationality Austria
CitizenshipAustrian, German
Education University of Salzburg
New York University
Occupation CEO of Roche
Children3

Dr. Thomas Schinecker (born April 23, 1975 in Simbach am Inn) is an Austrian-German pharmaceutical executive and the chief executive officer of the Roche Group since March 2023. He succeeded Severin Schwan, who was elected chairman of the board of directors of the Roche Group. [2] [3] [4]

Contents

Early life

Schinecker was born to an Austrian father and German mother in Simbach am Inn, Germany. [5] From the age of nine, he grew up in Singapore as the son of an ABB employee, and attended the German school. [6] [7] At the age of 19, he began studying genetics at the University of Salzburg, graduating with a bachelor's degree in 1997. He then continued his studies as a molecular biologist at New York University where he received his M.S in 2000 and Ph.D. in 2003. [8] [9] [10]

Career

In 2003, Schinecker joined the Roche Group as a management trainee working in the Roche diagnostics division in several countries. [11]

In 2005, he transitioned to the diagnostics field and assumed the position of Head of Marketing and Sales for Roche Diagnostics in Austria. [12] Subsequently, he held the role of General Manager for Roche Diagnostics in Sweden, followed by a two-year tenure in the United States. Later, he became the General Manager of Roche Diagnostics in Germany. [13] He was appointed CEO Roche Diagnostics in Rotkreuz, Switzerland in 2019. [14] Schinecker is known for leading the company's COVID-19 test kit efforts as the CEO of the Roche Diagnostics division. [15] [16] [17] [18]

In January 2023, he served ad-interim as CEO Roche Pharmaceuticals before taking on the position of CEO full-time in March 2023, succeeding Severin Schwan. [19] [20]

Memberships

Schinecker is a member of the Innovation Board of Labor Berlin (Charité and Vivantes). [21]

Since 2022, Schinecker serves as Vice-President of IFPMA. In November 2024, IFPMA announced that Schinecker would replace Albert Bourla as President. [22]

Personal life

Schinecker is married and has three children. The family has lived in Rotkreuz, Switzerland since 2017. He plays basketball, volleyball and squash. [6] [23]

Related Research Articles

<span class="mw-page-title-main">Roche</span> Swiss multinational healthcare company

F. Hoffmann-La Roche AG, commonly known as Roche, is a Swiss multinational holding healthcare company that operates worldwide under two divisions: Pharmaceuticals and Diagnostics. Its holding company, Roche Holding AG, has shares listed on the SIX Swiss Exchange. The company headquarters are located in Basel. Roche is the fifth-largest pharmaceutical company in the world by revenue and the leading provider of cancer treatments globally. In 2023, the company’s seat in Forbes Global 2000 was 76.

<span class="mw-page-title-main">Ricola</span> Swiss confectionery company

Ricola Ltd./RicolaAG is a Swiss manufacturer of cough drops, instant tea, tea bags, and breath mints. The head office of Ricola is located in Laufen, Basel-Country and has subsidiaries in Italy, Great Britain, Asia, and the United States. According to the company, it exports to around 45 countries in Europe, Asia, and North America.

The International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) is a trade association that represents internationally over 90 pharmaceutical companies and associations around the world. IFPMA is based in Geneva and is in official relations with the United Nations where it contributes industry expertise to global health discussions.

Bernina International AG is a privately owned international manufacturer of sewing and embroidery systems. The company was founded in Steckborn, Switzerland, and develops, manufactures, and sells goods and services for the textile market, primarily household sewing-related products in the fields of embroidery, quilting, home textiles, garment sewing, and crafting.

<span class="mw-page-title-main">FC Winterthur</span> Association football club from Winterthur

FC Winterthur is a Swiss football club based in Winterthur, Canton of Zürich. They play in the Swiss Super League, the first tier of Swiss football, and appeared regularly in the Nationalliga A during the 20th century. Their home is the Stadion Schützenwiese.

Illumina, Inc. is an American biotechnology company, headquartered in San Diego, California. Incorporated on April 1, 1998, Illumina develops, manufactures, and markets integrated systems for the analysis of genetic variation and biological function. The company provides a line of products and services that serves the sequencing, genotyping and gene expression, and proteomics markets, and serves more than 155 countries.

<span class="mw-page-title-main">Gruner + Jahr</span> Publishing house

Gruner + Jahr GmbH is a publishing house headquartered in Hamburg, Germany. The company was founded in 1965 by Richard Gruner, John Jahr, and Gerd Bucerius. From 1969 to 1973, Bertelsmann acquired a majority share in the company and gradually increased it over time. After 2014, the company was a fully owned subsidiary of the Gütersloh-based media and services group. Under the leadership and innovation strategy of Julia Jäkel, Gruner + Jahr evolved into a publishing house producing cross-channel media products for the digital society.

Mammut Sports Group AG is a Swiss manufacturer of clothing and equipment for alpine sports such as climbing, snow sports and trail running as well as trekking. The company was originally founded in 1862 as a ropemaker and has been part of the investment company Telemos Capital since 2021.

<span class="mw-page-title-main">Lonza Group</span> Swiss pharmaceutical and biotech company

Lonza Group AG is a Swiss multinational manufacturing company for the pharmaceutical, biotechnology and nutrition sectors, headquartered in Basel, with major facilities in Europe, North America and South Asia. Lonza was established under that name in the late 19th-century in Switzerland. The company provides product development services to the pharmaceutical and biologic industries, including custom manufacturing of biopharmaceuticals and detection systems and services for the bioscience sector.

<span class="mw-page-title-main">Severin Schwan</span> Businessman (born 1967)

Severin Anton Schwan is an Austrian business executive. He is the current chairman of the board and former CEO (2008–2023) of the Roche Group.

Cornelius Meister (born 23 February 1980 in Hannover, is a German conductor and pianist.

<span class="mw-page-title-main">Franz Humer</span> Swiss-Austrian businessman

Franz Bernhard Humer is a Swiss-Austrian businessman, and the former chairman of Diageo, and of Roche.

<span class="mw-page-title-main">Stefan Oschmann</span> German businessman (born 1957)

Stefan Oschmann is a German businessman. He was the CEO of pharma group Merck.

<span class="mw-page-title-main">Max Felchlin</span> Swiss manufacturer of confectionery and baking ingredients

Max Felchlin AG is a company headquartered in Schwyz, Switzerland which produces chocolate and other baking and confectionery ingredients.

<span class="mw-page-title-main">Urs Rohner</span> Swiss lawyer, businessman and banker (born December 1, 1959)

Urs Rohner is a Swiss lawyer, businessman and banker. He is the former CEO of ProSiebenSat.1 Media and former chairman of Swiss bank Credit Suisse. After his 10 year tenure the share price lost 75% of its value leaving the bank engulfed in various scandals and subsequently apologizing for his poor performance at the last shareholder meeting. He is considered one of the worst chairmen in Swiss banking.

<span class="mw-page-title-main">Fritz Gerber</span> Swiss business executive (1929–2020)

Fritz Gerber was a Swiss business executive. He was the Chief Executive Officer of Hoffmann-La Roche from 1978 to 1998. From 1977 to 1991, he was also the CEO of Zurich Insurance Group. Under his management, Roche expanded to become a significant player in biotechnology and diagnostics.

The Lucerne School of Computer Science and Information Technology is a professional school for information technology (IT) in Switzerland. Often called just School of Information Technology, it is a division of the Lucerne University of Applied Sciences and Arts. The campus is in Rotkreuz in Kanton Zug.

The 2022–23 Swiss Super League was the 126th season of top-tier competitive football in Switzerland and the 20th under its current name and format. With this season, the Swiss Super League became the longest continuously running top-flight national league.

The 2022–23 Swiss Cup, or Schweizer Pokal, was the 98th season of Switzerland's annual football cup competition. It featured 64 teams from the first to the eight tier of the Swiss football league. The first round was played from 19 to 21 August 2022. The final took place on 4 June 2023.

HBM Healthcare Investments is a publicly traded Swiss investment and venture capital firm focusing on emerging technologies in the global healthcare sector. Within healthcare their focus is predominantly in biotechnology, medical technology, diagnostics, therapeutics and digital health.

References

  1. ↑ "Curriculum Vitae" (PDF). Retrieved 24 April 2023.
  2. ↑ "Roche's chief executive to step down and become chair". Financial Times. 2022-07-21. Archived from the original on 2023-04-25. Retrieved 2023-04-25.
  3. ↑ OLOF-ORS, Nathalie. "Roche Set For Shake-up At The Top". www.barrons.com. Archived from the original on 2023-05-30. Retrieved 2023-05-30.
  4. ↑ "Pharma: Der neue CEO Thomas Schinecker muss Roche wieder vorwärtsbringen". Handelszeitung (in Swiss High German). Archived from the original on 2023-04-02. Retrieved 2023-05-30.
  5. ↑ "Schinecker folgt Redmann". www.mannheimer-morgen.de (in German). 2013-07-02. Retrieved 2024-08-12.
  6. 1 2 "Interview mit neuem Roche-Chef – "Wir werden dieses Jahr mehr in Forschung und Entwicklung investieren"". Tages-Anzeiger (in German). 15 March 2023. Archived from the original on 2023-04-25. Retrieved 2023-04-25.
  7. ↑ Eric Nolmans: Roche-CEO Thomas Schinecker will im laufenden Jahr 15 Milliarden in die Forschung stecken. Archived 2023-04-02 at the Wayback Machine In: Bilanz. Nr. 4, 2023, S. 54–60.
  8. ↑ "Curriculum Vitae" (PDF). Archived (PDF) from the original on 2023-05-15. Retrieved 2023-04-24.
  9. ↑ "Auf den stillen Schaffer Thomas Schinecker warten bei Roche grosse Aufgaben". Neue Zürcher Zeitung.
  10. ↑ Feldges, Dominik (2023-03-14). "Auf den stillen Schaffer Thomas Schinecker warten bei Roche grosse Aufgaben". Neue Züricher Zeitung. Retrieved 2023-05-30.
  11. ↑ Roche Diagnostics CEO: GenMark deal will further expand global reach, archived from the original on 2023-05-30, retrieved 2023-05-30
  12. ↑ Eric Nolmans: Roche-CEO Thomas Schinecker will im laufenden Jahr 15 Milliarden in die Forschung stecken. Archived 2023-04-02 at the Wayback Machine In: Bilanz. Nr. 4, 2023, S. 54–60.
  13. ↑ "Roche | Dr. Thomas Schinecker". www.roche.com (in German). Archived from the original on 2024-07-19. Retrieved 2024-08-12.
  14. ↑ "Roche promotes point-of-care head Schinecker to diagnostics CEO". Fiercebiotech. Archived from the original on 2024-08-12. Retrieved 2024-08-12.
  15. ↑ Burger, Ludwig (2022-07-21). "Roche diagnostics head to take helm of Swiss pharma giant". Reuters. Archived from the original on 2023-04-24. Retrieved 2023-04-24.
  16. ↑ swissinfo.ch/jdp (26 December 2021). "Roche at-home Covid tests receive US FDA nod". SWI swissinfo.ch. Archived from the original on 2023-04-24. Retrieved 2023-04-24.
  17. ↑ Weiland, Noah; Thomas, Katie (2020-03-13). "Trump Administration Moves to Speed Coronavirus Testing". The New York Times. ISSN   0362-4331. Archived from the original on 2023-04-23. Retrieved 2023-04-24.
  18. ↑ Miller, Robert (2023-05-30). "Faster Roche coronavirus test receives US Food and Drug Administration backing". The Times . ISSN   0140-0460. Archived from the original on 2023-05-30. Retrieved 2023-05-30.
  19. ↑ "Roche Annual General Meeting 2023". www.roche.com. Retrieved 2023-04-24.
  20. ↑ Roland, Denise (2022-07-21). "Roche CEO Severin Schwan to Step Down Next Year". Wall Street Journal. ISSN   0099-9660. Archived from the original on 2023-05-30. Retrieved 2023-05-30.
  21. ↑ "Innovation". Labor Berlin (in German). Archived from the original on 2023-04-24. Retrieved 2023-04-24.
  22. ↑ "Roche CEO named as new president of IFPMA". www.thepharmaletter.com. Retrieved 2024-11-27.
  23. ↑ Feldges, Dominik. "Thomas Schinecker tritt bei Roche ein schwieriges Erbe an". Neue Zürcher Zeitung (in Swiss High German). Archived from the original on 2023-04-24. Retrieved 2023-04-24.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.